RENAL FAILURE, END-STAGE

Clinical trials for RENAL FAILURE, END-STAGE explained in plain language.

Never miss a new study

Get alerted when new RENAL FAILURE, END-STAGE trials appear

Sign up with your email to follow new studies for RENAL FAILURE, END-STAGE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

First look: how a new drug behaves in failing kidneys

Knowledge-focused Completed

This study aimed to understand how the experimental drug MK-5684 is processed by the body in men with severe or end-stage kidney disease. Researchers compared drug levels in the blood of 24 men—some with kidney disease and some healthy—after a single dose. The goal was to see if …

Matched conditions: RENAL FAILURE, END-STAGE

Phase: PHASE1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Knowledge-focused

Last updated Apr 01, 2026 14:42 UTC

RENAL FAILURE, END-STAGE

Get alerted when new RENAL FAILURE, END-STAGE trials appear

First look: how a new drug behaves in failing kidneys